title: Functional significance of colocalization of PACAP and catecholamine in nerve terminals.
abstract: Medullary neurons containing pituitary adenylate cyclase-activating polypeptide (PACAP) and noradrenalin (NA) project to the hypothalamus and they are involved in the regulation of arginine vasopressin (AVP) neurons. At the ultrastructural level, PACAP immunoreactivity was detected in the granular vesicles in catecholaminergic nerve terminals that made synaptic contact with AVP neurons. Both PACAP (at least 1 nM) and NA (at least 1 microM) induced large increases in the cytosolic Ca2+ concentration ([Ca2+]i) in isolated AVP cells. PACAP at 0.1 nM and NA at 0.1 microM had little effects, if any, on [Ca2+]i. However, when 0.1 nM PACAP and 0.1 microM NA were combined, they evoked large increase in [Ca2+]i in AVP neurons. An inhibitor of protein kinase A (PKA) completely inhibited the PACAP-induced increase in [Ca2+]i, but only partly inhibited the NA-induced increase in [Ca2+]i. In AVP cells that were prelabeled with quinacrine, PACAP and NA acted synergistically to induce a loss of quinacrine fluorescence, indicating secretion of neurosecretory granules in AVP neurons. The results suggest that PACAP and NA, coreleased from the same nerve terminals, act in synergy to evoke calcium signaling and secretion in AVP neurons, and that the synergism is mediated by the interaction between cAMP-PKA pathway an as yet unidentified factor "X" linked to L-type Ca2+ channels. The synergism between PACAP and NA may contribute to the regulation of AVP secretion under physiological conditions.
authors.affiliation: Department of Anatomy, Showa University School of Medicine, Tokyo 142-8555, Japan. shioda@med.showa-u.ac.jp
authors.forename: S
authors.initials: S
authors.lastname: Shioda
authors.forename: T
authors.initials: T
authors.lastname: Yada
authors.forename: S
authors.initials: S
authors.lastname: Muroya
authors.forename: S
authors.initials: S
authors.lastname: Uramura
authors.forename: S
authors.initials: S
authors.lastname: Nakajo
authors.forename: H
authors.initials: H
authors.lastname: Ohtaki
authors.forename: T
authors.initials: T
authors.lastname: Hori
authors.forename: Y
authors.initials: Y
authors.lastname: Shimoda
authors.forename: H
authors.initials: H
authors.lastname: Funahashi
mesh_terms: D000818:Animals; D001127:Arginine Vasopressin / Q000378:metabolism; D020013:Calcium Signaling; D007150:Immunohistochemistry; D008297:Male; D009411:Nerve Endings / Q000378:metabolism*; D009479:Neuropeptides / Q000378:metabolism*; D009638:Norepinephrine / Q000378:metabolism*; D051219:Pituitary Adenylate Cyclase-Activating Polypeptide; D051381:Rats; D017207:Rats, Sprague-Dawley; D013495:Supraoptic Nucleus / Q000378:metabolism
chemical_list: C495403:Adcyap1 protein, rat; D009479:Neuropeptides; D051219:Pituitary Adenylate Cyclase-Activating Polypeptide; D001127:Arginine Vasopressin; D009638:Norepinephrine